116 related articles for article (PubMed ID: 30339745)
61. Hepatitis C virus is restricted at both entry and replication in mouse hepatocytes.
Park IW; Ndjomou J; Fan Y; Henao-Mejia J; He JJ
Biochem Biophys Res Commun; 2009 Sep; 387(3):489-93. PubMed ID: 19619513
[TBL] [Abstract][Full Text] [Related]
62. Determinants in the Ig Variable Domain of Human HAVCR1 (TIM-1) Are Required To Enhance Hepatitis C Virus Entry.
Kachko A; Costafreda MI; Zubkova I; Jacques J; Takeda K; Wells F; Kaplan G; Major ME
J Virol; 2018 Mar; 92(6):. PubMed ID: 29321304
[TBL] [Abstract][Full Text] [Related]
63. Ceramide enrichment of the plasma membrane induces CD81 internalization and inhibits hepatitis C virus entry.
Voisset C; Lavie M; Helle F; Op De Beeck A; Bilheu A; Bertrand-Michel J; Tercé F; Cocquerel L; Wychowski C; Vu-Dac N; Dubuisson J
Cell Microbiol; 2008 Mar; 10(3):606-17. PubMed ID: 17979982
[TBL] [Abstract][Full Text] [Related]
64. Claudin-1 required for HCV virus entry has high potential for phosphorylation and O-glycosylation.
Ahmad W; Shabbiri K; Ijaz B; Asad S; Sarwar MT; Gull S; Kausar H; Fouzia K; Shahid I; Hassan S
Virol J; 2011 May; 8():229. PubMed ID: 21569618
[TBL] [Abstract][Full Text] [Related]
65. SRFBP1, an Additional Player in HCV Entry.
Fénéant L; Cocquerel L
Trends Microbiol; 2015 Oct; 23(10):590-593. PubMed ID: 26319372
[TBL] [Abstract][Full Text] [Related]
66. Intracellular delivery of serum-derived hepatitis C virus.
Fukuhara T; Tani H; Shiokawa M; Goto Y; Abe T; Taketomi A; Shirabe K; Maehara Y; Matsuura Y
Microbes Infect; 2011 Apr; 13(4):405-12. PubMed ID: 21262370
[TBL] [Abstract][Full Text] [Related]
67. Differential interaction strategies of hepatitis c virus genotypes during entry - An in silico investigation of envelope glycoprotein E2 - CD81 interaction.
Bhattacharjee C; Nandy SK; Das P; Mukhopadhyay A
Infect Genet Evol; 2019 Apr; 69():48-60. PubMed ID: 30639544
[TBL] [Abstract][Full Text] [Related]
68. Regulated Entry of Hepatitis C Virus into Hepatocytes.
Miao Z; Xie Z; Miao J; Ran J; Feng Y; Xia X
Viruses; 2017 May; 9(5):. PubMed ID: 28486435
[TBL] [Abstract][Full Text] [Related]
69. MiR-122 decreases HCV entry into hepatocytes through binding to the 3' UTR of OCLN mRNA.
Sendi H; Mehrab-Mohseni M; Foureau DM; Ghosh S; Walling TL; Steuerwald N; Zamor PJ; Kaplan KJ; Jacobs C; Ahrens WA; Russo MW; Clemens MG; Schrum LW; Bonkovsky HL
Liver Int; 2015 Apr; 35(4):1315-23. PubMed ID: 25302477
[TBL] [Abstract][Full Text] [Related]
70. The mechanism of HCV entry into host cells.
Douam F; Lavillette D; Cosset FL
Prog Mol Biol Transl Sci; 2015; 129():63-107. PubMed ID: 25595801
[TBL] [Abstract][Full Text] [Related]
71. Interaction of hepatitis C virus-like particles and cells: a model system for studying viral binding and entry.
Triyatni M; Saunier B; Maruvada P; Davis AR; Ulianich L; Heller T; Patel A; Kohn LD; Liang TJ
J Virol; 2002 Sep; 76(18):9335-44. PubMed ID: 12186916
[TBL] [Abstract][Full Text] [Related]
72. Monoclonal antibodies against extracellular domains of claudin-1 block hepatitis C virus infection in a mouse model.
Fukasawa M; Nagase S; Shirasago Y; Iida M; Yamashita M; Endo K; Yagi K; Suzuki T; Wakita T; Hanada K; Kuniyasu H; Kondoh M
J Virol; 2015 May; 89(9):4866-79. PubMed ID: 25673725
[TBL] [Abstract][Full Text] [Related]
73. Nonstructural 3 Protein of Hepatitis C Virus Modulates the Tribbles Homolog 3/Akt Signaling Pathway for Persistent Viral Infection.
Tran SC; Pham TM; Nguyen LN; Park EM; Lim YS; Hwang SB
J Virol; 2016 Aug; 90(16):7231-7247. PubMed ID: 27252525
[TBL] [Abstract][Full Text] [Related]
74. New cell culture models of hepatitis C virus entry, replication, and virus production.
Lindenbach BD
Gastroenterology; 2010 Oct; 139(4):1090-3. PubMed ID: 20797436
[No Abstract] [Full Text] [Related]
75. Live Cell Imaging of Hepatitis C Virus Trafficking in Hepatocytes.
Baktash Y; Randall G
Methods Mol Biol; 2019; 1911():263-274. PubMed ID: 30593632
[TBL] [Abstract][Full Text] [Related]
76. Population genetics and comparative genetics of CLDN1, a gene involved in hepatitis C virus entry.
Bekker V; O'Brien TR; Chanock S
Hum Hered; 2009; 67(3):206-16. PubMed ID: 19077439
[TBL] [Abstract][Full Text] [Related]
77. An unexpected link between HCV and platelets.
Alter HJ
Blood; 2001 Oct; 98(8):2291. PubMed ID: 11588019
[No Abstract] [Full Text] [Related]
78. Murine SEC24D can substitute functionally for SEC24C during embryonic development.
Adams EJ; Khoriaty R; Kiseleva A; Cleuren ACA; Tomberg K; van der Ent MA; Gergics P; Tang VT; Zhu G; Hoenerhoff MJ; O'Shea KS; Saunders TL; Ginsburg D
Sci Rep; 2021 Oct; 11(1):21100. PubMed ID: 34702932
[TBL] [Abstract][Full Text] [Related]
79. Pseudotyped Virus for Flaviviridae.
Zhang L; Wang X; Ming A; Tan W
Adv Exp Med Biol; 2023; 1407():313-327. PubMed ID: 36920705
[TBL] [Abstract][Full Text] [Related]
80. Tight Junctions, the Key Factor in Virus-Related Disease.
Ding G; Shao Q; Yu H; Liu J; Li Y; Wang B; Sang H; Li D; Bing A; Hou Y; Xiao Y
Pathogens; 2022 Oct; 11(10):. PubMed ID: 36297257
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
